Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jul 09, 2014 11:21am
198 Views
Post# 22728828

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DO BLOOD LEVELS OF APOA-1 REALLY MATTER SO MUCH????

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DO BLOOD LEVELS OF APOA-1 REALLY MATTER SO MUCH????Hi GV and thanks for the perspective.

I fully accept your first paragraph and I'm glad you provided that perspective. These are highly motivated people. I have a good sense of that because in one of my corporate jobs my entire department were PhDs and they were highly motivated and success driven.

In fact, highly motivated and successful scientists could be part of the brand positioning.

Regarding the second paragraph you make many good points but I'm in general disagreement. Let me give some perspectives.
  1. Regarding Nike - Yes it is a different target market and they address their targets needs accordingly. I did a large brand positioning project to build an umbrella brand for the 13 safety associations of Ontario. I used Tim Hortons (a coffee & donut chain in Canada) as a positioning example - Tim Hortons -Always Fresh - as an example of brilliant brand positioning for many resaons which I won't get into. They rejected this example because they said safety deals with injury, death and impairment, very serious stuff. So I explained that Tim Horton's was just a particular example of brand positioning and that they needed to develop their positioning based to their target markets needs...all of the employees and employers working in every sector in Ontario. This group of people (safety groups) described themselves in functional terms e.g. we have pamphlets on prevention, we do seminars at the workplace,etc. Very boring stuff. So I said why don't you explore branding opportunities like what does "safety" mean to you customers e.g. it gets them home to their family, each day, it is part of their health, it means employees work together and protect each other, hope,security in numbers, etc. We did close to 50 focus groups across Ontario with employers and employees. We were able to create an umbrella brand for the 13 groups and provided brand positioning concepts for each sub-group.
  2. Regarding biotech being boring - Not if you consider it's relevance in terms of human health and it's potential impact on CV diseases, cancer, etc.
  3. Regarding BP doing the branding - Right now the brand is RVX and it's target market is the broad of all investors.
  4. Nothing to sell - There's lot's to sell and also the hope of scoring big on a small investment.
  5. Budgets - RVX does not need a big marketing budget. It's not going to buy TV media. It needs a smart marketing kid with PR experience and very stong skills in social media.
  6. RVX around for ten years - Yes and lots of blogs about it's failures. That is precisely why it needs to be positioned on it's successes. Remember much of the bitterness comes from people who bought in at $25 and later $8 on another cycle. Keep in mind that the trial results last June were a near hit and should have been positioned that way.

I better take my RVX pill.
Cheers
Toinv
Bullboard Posts